BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhou HJ, Dan YY, Naidoo N, Li SC, Yeoh KG. A cost-effectiveness analysis evaluating endoscopic surveillance for gastric cancer for populations with low to intermediate risk. PLoS One 2013;8:e83959. [PMID: 24386314 DOI: 10.1371/journal.pone.0083959] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 2.9] [Reference Citation Analysis]
Number Citing Articles
1 Choi KS, Suh M. Screening for gastric cancer: the usefulness of endoscopy. Clin Endosc. 2014;47:490-496. [PMID: 25505713 DOI: 10.5946/ce.2014.47.6.490] [Cited by in Crossref: 47] [Cited by in F6Publishing: 42] [Article Influence: 5.9] [Reference Citation Analysis]
2 Choi IJ. Endoscopic gastric cancer screening and surveillance in high-risk groups. Clin Endosc. 2014;47:497-503. [PMID: 25505714 DOI: 10.5946/ce.2014.47.6.497] [Cited by in Crossref: 41] [Cited by in F6Publishing: 40] [Article Influence: 5.1] [Reference Citation Analysis]
3 Shah SC, Itzkowitz SH, Jandorf L. Knowledge Gaps among Physicians Caring for Multiethnic Populations at Increased Gastric Cancer Risk. Gut Liver 2018;12:38-45. [PMID: 28873510 DOI: 10.5009/gnl17091] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
4 Banks M, Graham D, Jansen M, Gotoda T, Coda S, di Pietro M, Uedo N, Bhandari P, Pritchard DM, Kuipers EJ, Rodriguez-Justo M, Novelli MR, Ragunath K, Shepherd N, Dinis-Ribeiro M. British Society of Gastroenterology guidelines on the diagnosis and management of patients at risk of gastric adenocarcinoma. Gut 2019;68:1545-75. [PMID: 31278206 DOI: 10.1136/gutjnl-2018-318126] [Cited by in Crossref: 170] [Cited by in F6Publishing: 142] [Article Influence: 56.7] [Reference Citation Analysis]
5 Areia M, Spaander MC, Kuipers EJ, Dinis-Ribeiro M. Endoscopic screening for gastric cancer: A cost-utility analysis for countries with an intermediate gastric cancer risk. United European Gastroenterol J. 2018;6:192-202. [PMID: 29511549 DOI: 10.1177/2050640617722902] [Cited by in Crossref: 33] [Cited by in F6Publishing: 27] [Article Influence: 6.6] [Reference Citation Analysis]
6 Sugano K. Screening of gastric cancer in Asia. Best Pract Res Clin Gastroenterol. 2015;29:895-905. [PMID: 26651251 DOI: 10.1016/j.bpg.2015.09.013] [Cited by in Crossref: 103] [Cited by in F6Publishing: 100] [Article Influence: 14.7] [Reference Citation Analysis]
7 Xia R, Zeng H, Liu W, Xie L, Shen M, Li P, Li H, Wei W, Chen W, Zhuang G. Estimated Cost-effectiveness of Endoscopic Screening for Upper Gastrointestinal Tract Cancer in High-Risk Areas in China. JAMA Netw Open 2021;4:e2121403. [PMID: 34402889 DOI: 10.1001/jamanetworkopen.2021.21403] [Reference Citation Analysis]
8 Suh Y, Lee J, Woo H, Shin D, Kong S, Lee H, Shin A, Yang H. National cancer screening program for gastric cancer in Korea: Nationwide treatment benefit and cost. Cancer 2020;126:1929-39. [DOI: 10.1002/cncr.32753] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
9 Shen M, Xia R, Luo Z, Zeng H, Wei W, Zhuang G, Zhang L, Chen W. The long-term population impact of endoscopic screening programmes on disease burdens of gastric cancer in China: A mathematical modelling study. J Theor Biol 2020;484:109996. [PMID: 31491497 DOI: 10.1016/j.jtbi.2019.109996] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
10 Matsuda A, Saika K, Tanaka R, Ito Y, Fukui K, Kamo KI. Simulation Models in Gastric Cancer Screening: A Systematic Review. Asian Pac J Cancer Prev 2018;19:3321-34. [PMID: 30583337 DOI: 10.31557/APJCP.2018.19.12.3321] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
11 Jun JK, Choi KS, Lee HY, Suh M, Park B, Song SH, Jung KW, Lee CW, Choi IJ, Park EC, Lee D. Effectiveness of the Korean National Cancer Screening Program in Reducing Gastric Cancer Mortality. Gastroenterology. 2017;152:1319-1328.e7. [PMID: 28147224 DOI: 10.1053/j.gastro.2017.01.029] [Cited by in Crossref: 145] [Cited by in F6Publishing: 127] [Article Influence: 29.0] [Reference Citation Analysis]
12 Kowada A. Cost-effectiveness of Helicobacter pylori test and eradication versus upper gastrointestinal series versus endoscopy for gastric cancer mortality and outcomes in high prevalence countries. Scandinavian Journal of Gastroenterology 2019;54:685-9. [DOI: 10.1080/00365521.2019.1627408] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
13 Sato S, Fushimi S, Tahata Y, Mizutamari H, Mimori N, Kato Y, Horikawa Y. Feasibility of Endoscopic Screening for Upper Gastrointestinal Malignancy in a Comprehensive Health Checkup. Intern Med 2021;60:1493-9. [PMID: 33328405 DOI: 10.2169/internalmedicine.6020-20] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
14 Prinz F, Ebigbo A, Probst A, Messmann H. Gastric cancer- endoscopic treatment of early lesions, the West learns from the East. Best Pract Res Clin Gastroenterol 2021;50-51:101739. [PMID: 33975685 DOI: 10.1016/j.bpg.2021.101739] [Reference Citation Analysis]
15 Laird-Fick HS, Saini S, Hillard JR. Gastric adenocarcinoma: the role of Helicobacter pylori in pathogenesis and prevention efforts. Postgrad Med J. 2016; May 24. [Epub ahead of print]. [PMID: 27222587 DOI: 10.1136/postgradmedj-2016-133997] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
16 Kapoor R, So JBY, Zhu F, Too HP, Yeoh KG, Yoong JS. Evaluating the Use of microRNA Blood Tests for Gastric Cancer Screening in a Stratified Population-Level Screening Program: An Early Model-Based Cost-Effectiveness Analysis. Value Health 2020;23:1171-9. [PMID: 32940235 DOI: 10.1016/j.jval.2020.04.1829] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
17 Arribas Anta J, Dinis-Ribeiro M. Early gastric cancer and Artificial Intelligence: Is it time for population screening?Best Pract Res Clin Gastroenterol. 2021;52-53:101710. [PMID: 34172244 DOI: 10.1016/j.bpg.2020.101710] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
18 Saumoy M, Schneider Y, Shen N, Kahaleh M, Sharaiha RZ, Shah SC. Cost Effectiveness of Gastric Cancer Screening According to Race and Ethnicity. Gastroenterology 2018;155:648-60. [DOI: 10.1053/j.gastro.2018.05.026] [Cited by in Crossref: 53] [Cited by in F6Publishing: 41] [Article Influence: 13.3] [Reference Citation Analysis]
19 Eusebi LH, Telese A, Marasco G, Bazzoli F, Zagari RM. Gastric cancer prevention strategies: A global perspective. J Gastroenterol Hepatol 2020;35:1495-502. [PMID: 32181516 DOI: 10.1111/jgh.15037] [Cited by in Crossref: 34] [Cited by in F6Publishing: 37] [Article Influence: 17.0] [Reference Citation Analysis]
20 Khanderia E, Markar SR, Acharya A, Kim Y, Kim YW, Hanna GB. The Influence of Gastric Cancer Screening on the Stage at Diagnosis and Survival: A Meta-Analysis of Comparative Studies in the Far East. J Clin Gastroenterol. 2016;50:190-197. [PMID: 26844858 DOI: 10.1097/mcg.0000000000000466] [Cited by in Crossref: 19] [Cited by in F6Publishing: 11] [Article Influence: 3.2] [Reference Citation Analysis]
21 Sánchez-Barriga JJ. Mortality trends and years of potential life lost from gastric cancer in Mexico, 2000-2012. Rev Gastroenterol Mex 2016;81:65-73. [PMID: 26987425 DOI: 10.1016/j.rgmx.2016.01.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
22 Kowada A. Endoscopy Is Cost-Effective for Gastric Cancer Screening After Successful Helicobacter pylori Eradication. Dig Dis Sci 2021. [PMID: 33417196 DOI: 10.1007/s10620-020-06813-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
23 Canakis A, Pani E, Saumoy M, Shah SC. Decision model analyses of upper endoscopy for gastric cancer screening and preneoplasia surveillance: a systematic review. Therap Adv Gastroenterol 2020;13:1756284820941662. [PMID: 32728390 DOI: 10.1177/1756284820941662] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]